MOLLY WARNOCK: Open Payments
NPI 1821628751 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,246 in 109 payments from 21 companies in 2025. Trend: 2023 $1,759 · 2024 $1,890 · 2025 $2,246
Food & beverage: $2,246
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $271 |
| PFIZER INC. | 7 | $251 |
| Incyte Corporation | 11 | $235 |
| Janssen Biotech, Inc. | 14 | $212 |
| Galderma Laboratories, L.P. | 10 | $174 |
| GENZYME CORPORATION | 5 | $167 |
| Regeneron Healthcare Solutions, Inc. | 14 | $160 |
| UCB, Inc. | 5 | $129 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Organon LLC | 5 | $92 |
Products named: DUPIXENT, CIBINQO, OPZELURA, TREMFYA, SKYRIZI, Bimzelx, RINVOQ, COSENTYX.
Industry payments across MD — which companies pay providers there.
